Lansoprazole increases serum IgG and IgM in H. pylori-infected patients

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 1, 2007, Pages 173-179

  Matsukawa, Yoshihiro ^a   Kurosaka, H ^b   Kato, K ^a   Hayashi, I ^c   Minekawa, K ^d   Arakawa, Y ^a   Sawada, S ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kurosaka Clinic   (Japan)

^c Kamifukuoka Kyodo Clinic Fujimino City   (Japan)

^d Kawaguchi Municipal Medical Center   (Japan)

Author keywords

Gastric ulcer; Helicobacter pylori; Immunoglobulin; Lansoprazole; Non steroidal anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH ULCER; TH1 CELL; TREATMENT DURATION;

EID: 33947719357     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000120     Document Type: Article

References (23)

1. Matsukawa Y., S. Sawada and T. Horie. 1992. Effect of famotidine on various immunological parameters in patients with rheumatic diseases: decreased lymphocyte DR expression by famotidine. Immunopharmacol. Immunotoxicol. 14:477.
2. Kountouras J., P. Boura, G. Apostolides, E. Zaharioudaki and G. Tsapas. 1994. In vitro effect of omeprazole on HLA-DR expression and the monocyte-macrophage function in patients with duodenal ulcer disease. Immunopharmacol. Immunotoxicol. 16:437.
3. Capodicasa E., F. De Bellis and M.A. Pelli. 1999. Effect of lansoprazole on human leukocyte function. Immunopharmacol. Immunotoxicol. 21:357.
4. Kountouras J., P. Boura and N.L. Lygidakis. 2000. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology 47:1301.
5. Megraud F., L. Boyanova and H. Lamouliatte. 1991. Activity of lansoprazole against Helicobacter pylori. Lancet 337:1486.
6. Iwahi T., H. Satoh, M. Nakao, T. Iwasaki, T. Yamazaki, K. Kubo, T. Tamura and A. Imada. 1991. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. 35:490.
7. Nagata K., H. Satoh, T. Iwahi, T. Shimoyama and T. Tamura. 1993. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori. Antimicrob. Agents Chemother. 37:769.
8. McGowan C.C., T.L. Cover and M. Blaser. 1994 The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 107:738.
9. Matsukawa Y., S. Nishinarita, M. Kaneko, M. Takei, M. Murakami, T. Horie, F. Kawamura, Y. Arakawa, H. Kuwayama and H. Kurosaka. 1997. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II. Int. J. Clin. Pharmacol. Res. 17:127.
10. Tsutsumi Y., H. Kanamori, H. Yamato, N. Ehira, T. Kawamura, S. Umehara, A. Mori, S. Obara, N. Ogura, J. Tanaka, M. Asaka, M. Imamura and N. Masauzi. 2005. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann. Hematol. 84:807.
11. Franch A., M. Castellote and M. Castell. 1994. Effect of acetylsalicylic acid and dexamethasone on antibody production in adjuvant arthritis. Rheumatol. Int. 14:27.
12. Mazzeo D., P. Panina-Bordignon, H. Recalde, F. Sinigaglia and D. D'Ambrosio. 1998. Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-kappa B. Eur. J. Immunol. 28:3205.
13. Yamaki K., H. Uchida, Y. Harada, R. Yanagisawa, H. Takano, H. Hayashi, Y. Mori and S. Yoshino. 2003. Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice. J. Pharmacol. Sci. 92:1723.
14. Andreone P., A. Gramenzi, E. Loggi, L. Favarelli, C. Cursaro, M. Margotti, M. Biselli, S. Lorenzini and M. Bernardi. 2004. In vivo effect of indomethacin and interferon-α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. Cytokine 26:95.
15. Moed H., T.J. Stoof, D.M. Boorsma, B.M. von Blomberg, S. Gibbs, D.P. Bruynzeel, R.J. Scheper and T. Rustemeyer. 2004. Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 cell profiles. Clin. Exp. Allergy 34:1868.
16. Yamaki K., H. Uchida, X. Li, R. Yanagisawa, H. Takano, H. Hayashi, Y. Mori and S. Yoshino. 2005. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 18:133.
17. Matsukawa Y., Y. Tomita, S. Nishinarita, T. Horie, K. Kato, Y. Arakawa, K. Ko, H. Shimada, M. Nakano, Y. Kitami and H. Hanzo. 1997. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing. J. Int. Med. Res. 25:190.
18. D'Elios M.M., M. Manghetti, M. De Carli, F. Costa, C.T. Baldari, D. Burroni, J.L. Telford, S. Romagnani and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962.
19. Sommer F., G. Faller, P. Kontrek, T. Kirchner, E.G. Hahn, J. Zeus, M. Rollinghoff and M. Lohoff. 1998. Antrum- and corpus mucosa-infiltrating CD4+ lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect. Immun. 66:5543.
20. Bamford K.B., X. Fan, S.E. Crowe, J.F. Leary, W.K. Gourley, G.K. Luthra, E.G. Brooks, D.Y. Graham, V.E. Reyes and P.B. Ernst. 1998. Lymphocytes in human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482.
21. Fan X., S.E. Crowe, S. Behr, H. Gunasena, G. Ye, H. Haeberle, N. Van Houten, W.K. Gourley, P.B. Ernst and V.E. Reyes. 1998. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 187:1659.
22. Tomita T., A.M. Jackson, N. Hida, M. Hayat, M.F. Dixon, T. Shimoyama, A.T. Axon, P.A. Robinson and J.E. Crabtree. 2001. Expression of interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J. Infect. Dis. 183:620.
23. Ihan A., B. Tepes and M. Gubina. 2000. Diminished Thl-type cytokine production in gastric mucosa T-lymphocytes after H. pylori eradication in duodenal ulcer patients. Pfluger. Arch. 440:89.